401915-55-7,
Fmoc-beta-Homogln(Trt)-OH,
Fmoc-beta-Hogln(Trt)-OH,
Fmoc-L-beta-homoglutamine(Trt),
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-oxo-6-(tritylamino)hexanoic acid,
Fmoc-beta-homo-Gln(TRT)-OH,
Fmoc-Ndelta-methyltrityl-L-glutamine,
MFCD03427580,
(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-6-oxo-6-(tritylamino)hexanoic acid,
Fmoc--HoGln(Trt)-OH Fmoc-L--Homoglutamine(Trt),
(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-6-keto-6-(tritylamino)hexanoic acid,
(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-6-oxidanylidene-6-[(triphenylmethyl)amino]hexanoic acid,
(3S)-3-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]-6-oxo-6-[(triphenylmethyl)amino]hexanoic acid,
AK-89140,
Fmoc-?-HoGln(Trt)-OH,
AC1MC54V,
Fmoc-b-Homo-Gln(Trt)-OH,
SCHEMBL178893,
CTK8F9909,
DTXSID50375811,
Fmoc-Ng-trityl-L-b-homoglutamine,
ZINC4240264,
5366AB,
CF-805,
AKOS015903178,
CS-W011425,
ACM401915557,
RT-013019,
FT-0696172,
A-7314,
L-3-(Fmoc-amino)-N-trityladipic acid 6-amide,
Fmoc-beta-Homogln(Trt)-OH, >=95.0% (HPLC),
(S)-3-(Fmoc-amino)-N-trityl-adipic acid 6-amide,
I14-18929,
(3S)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-(triphenylmethylcarbamoyl)pentanoic acid,
Fmoc-|A-HoGln(Trt)-OH,
Fmoc-L-beta-Homoarginine(Pmc),
C40H36N2O5,
Fmoc-beta-HoGln(Trt)-OH - 1G 1g,
ACN-034168,
CID2761519,
A7561,
144317-23-7,
3-(9H-fluoren-9-ylmethoxycarbonylamino)-5-(tritylcarbamoyl)pentanoic Acid,
700377-76-0,
Hexanoic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-6-oxo-6-[(triphenylmethyl)amino]-, (3S)-,